BofA analyst Allen Lutz raised the firm’s price target on Cencora (COR) to $285 from $270 and keeps a Neutral rating on the shares. The recent ...

Walgreens tackles declining profits, store closures, and rising costs. Learn about Sycamore Partners' acquisition offer of ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches.

Major indices skyrocketed on Wednesday as Donald Trump announced a 90-day pause to a number of his so-called "reciprocal" tariffs.

Adjusted earnings came in at $0.63 per share for the three-month period ended Feb. 28, exceeding analyst expectations of ...

Walgreens Boots Alliance reported stronger-than-expected second-quarter earnings Tuesday as the pharmacy chain accelerated ...

Pharmaceutical companies accused of fueling the nation's opioid crisis are paying state and local governments billions of ...

WBA's U.S. Retail Pharmacy segment had second quarter sales of $30.4 billion, an increase of 5.3% from the year-ago quarter.

The company is in the process of being taken private by Sycamore Partners in a deal that is expected to close in the fourth ...